tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CRISM Therapeutics Launches Retail Offer to Fund ChemoSeed Development

Story Highlights
CRISM Therapeutics Launches Retail Offer to Fund ChemoSeed Development

Elevate Your Investing Strategy:

Amur Minerals ( (GB:CRTX) ) has shared an update.

CRISM Therapeutics Corporation has announced a retail offer to raise up to £100,000 through the issuance of new ordinary shares at 12 pence per share. The proceeds from this offer, along with a separate placing, will fund the development of ChemoSeed, specifically for manufacturing and clinical trials aimed at evaluating its safety and efficacy in glioblastoma patients. The retail offer is open to eligible UK investors and is expected to close on July 2, 2025, with trading commencing on July 8, 2025.

More about Amur Minerals

Average Trading Volume: 67,074

Technical Sentiment Signal: Strong Buy

Current Market Cap: £1.83M

For an in-depth examination of CRTX stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1